Northwestern Mutual Wealth Management
KYMR icon

Northwestern Mutual Wealth Management’s Kymera Therapeutics KYMR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.25K Buy
39
+11
+39% +$871 ﹤0.01% 3449
2025
Q4 		$2.18K Buy
+28
New +$1.89K ﹤0.01% 3460
2023
Q3 		– Sell
-150
Closed -$3.45K – 3433
2023
Q2 		$3.45K Buy
150
+145
+2,900% +$4.16K ﹤0.01% 2879
2023
Q1 		$148 Buy
+5
New +$161 ﹤0.01% 3219

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Northwestern Mutual Wealth Management's KYMR Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Kymera Therapeutics (KYMR) stake by 39% in Q1 2026, buying an estimated $871 and bringing the position to 39 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #3449.

Northwestern Mutual Wealth Management first reported a position in KYMR in Q1 2023 and has held it in 4 quarters since. The position peaked at $3.45K in Q2 2023. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Northwestern Mutual Wealth Management held 39 shares of Kymera Therapeutics worth $3.25K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 11 Kymera Therapeutics shares in Q1 2026, an estimated $871.
  • Kymera Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3449 holding.
  • Northwestern Mutual Wealth Management first reported a position in Kymera Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Northwestern Mutual Wealth Management's Kymera Therapeutics position peaked at $3.45K in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.